The effect of flurbiprofen and tiaprofenic acid on serum cytokine levels of patients with osteoarthrosis

Acta Orthop Scand. 2001 Oct;72(5):499-502. doi: 10.1080/000164701753532844.

Abstract

39 patients with active knee osteoarthrosis, chosen according to ACR criteria, were assigned to receive flurbiprofen (n 12, 2 x 100 mg), tiaprofenic acid (n 14, 2 x 300 mg) and placebo (n 13) in a 3-week, placebo-controlled study. All patients completed the study, and both medications were found to be effective: improvement occurred in the clinical signs. These drugs reduced the TNF-alpha levels. Flurbiprofen especially affected the IL-6 levels. Our findings indicate that NSAIDs may be effective in the etiopathogenesis of osteoarthrosis.

Publication types

  • Clinical Trial
  • Comparative Study
  • Randomized Controlled Trial

MeSH terms

  • Adult
  • Aged
  • Anti-Inflammatory Agents, Non-Steroidal / therapeutic use*
  • Cytokines / blood*
  • Female
  • Flurbiprofen / therapeutic use*
  • Humans
  • Interleukin-1 / blood
  • Interleukin-6 / blood
  • Male
  • Middle Aged
  • Osteoarthritis, Knee / blood*
  • Osteoarthritis, Knee / drug therapy*
  • Pain Measurement
  • Propionates / therapeutic use*
  • Prospective Studies
  • Tumor Necrosis Factor-alpha / analysis

Substances

  • Anti-Inflammatory Agents, Non-Steroidal
  • Cytokines
  • Interleukin-1
  • Interleukin-6
  • Propionates
  • Tumor Necrosis Factor-alpha
  • tiaprofenic acid
  • Flurbiprofen